摘要 |
Histone deacetylase inhibitors and uses thereof are provided that have the general formula wherein R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3 </SUB>and R<SUB>4 </SUB>are each independently selected from the group consisting of hydrogen, a substituted or unsubstituted straight chained C<SUB>1-12 </SUB>alkyl, C<SUB>2-12 </SUB>aminoalkyl or C<SUB>2-12 </SUB>oxaalkyl, and a substituted and unsubstituted 3, 4, 5, 6, 7 or 8 membered ring, with the proviso that R<SUB>3 </SUB>and R<SUB>4 </SUB>are not both hydrogen; R<SUB>5 </SUB>is selected from the group consisting of a carbonyl, a substituted or unsubstituted C<SUB>1-3 </SUB>alkyl, a substituted or unsubstituted -C<SUB>1-3 </SUB>alkyl-C(O), a substituted or unsubstituted -C(O)-C<SUB>1-3 </SUB>alkyl, and a substituted or unsubstituted -C(O)C(O)C<SUB>1-3 </SUB>alkyl; M is a substituent capable of complexing with a protein metal ion; and L is a substituent comprising a chain of 3-12 atoms connecting the M substituent to the carbon atom alpha to the L substituent.
|